N-(4-Oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)isobutyramide

Catalog No. :
ACXDYK418
CAS No. :
2007908-78-1
Molecular Formula :
C10H12N4O2
Molecular Weight :
220.23

IUPAC Name:N-(4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)isobutyramide

N-(4-Oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)isobutyramide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$54.00Login to see priceIn stockInquiry
250mg97%$97.00Login to see priceIn stockInquiry
1g97%$243.00Login to see priceIn stockInquiry
5g97%$727.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)isobutyramide
IUPAC NameN-(4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-2-yl)isobutyramide
MDL No.MFCD30471378
Molecular FormulaC10H12N4O2
Molecular Weight220.23
SMILESCC(C)C(NC1=NC(NC=C2)=C2C(N1)=O)=O
InChI KeyKBQGJWWDPYKSFK-UHFFFAOYSA-N
SynonymN-(4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-2-YL)ISOBUTYRAMIDE
CAS No.2007908-78-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXDYK418 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDFIS845 route compound structure diagram
    ACDFIS8457355-55-7 In Stock
  4. Then
  5. ACXDYK418 route product structure diagram
    ACXDYK4182007908-78-1 In Stock
Inquiry

2. ACXDYK418 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDFIS845 route compound structure diagram
    ACDFIS8457355-55-7 In Stock
  4. Then
  5. ACXDYK418 route product structure diagram
    ACXDYK4182007908-78-1 In Stock
Inquiry

Comments (0)